Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению эрозивноязвенных поражений желудка и двенадцатиперстной кишки

1. Каратеев А.Е., Успенский Ю.П., Пахомова И.Г., Насонов Е.Л. Комбинированное лечение язв желудка, индуцированных нестероидными противовоспалительными препаратами. Результаты 4-недельного открытого контролируемого исследования по оценке эффективности комбинации ингибитора протонного насоса и висмута трикалия дицитрата. Тер арх 2009; 6:62-7.

2. Рекомендации Российской Гастроэнтерологической Ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых (Ивашкин В.Т., Маев И.В., Лапина Т.Л., Шептулин А.А. и др.). Рос журн гастроэнтерол гепатол колопроктол 2012; 22(1):87-9.

3. Bombardier C., Laine L., Reicin A., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis VIGOR Study Group. N Engl J Med 2000; 343:1520-8.

4. Chan F.K., Graham D.Y. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications – review and recommendations based on risk assessment. Aliment Pharmacol Ther 2004; 19:105161.

5. Chan F.K., To K.F., Wu J.C.Y., et al. A randomized double-blind trial to evaluate the gastroduodenal safety of oral meloxicam 7,5 mg once daily compared with oral piroxicam 20 mg once daily over a period of f our weeks in patients with osteoarthritis of the knee [Abstract]. Gut 2004; 53(suppl. 6):119.

6. Dajani E.Z., Islam K. Cardiovascular and gastrointestinal toxicity of selective cyclooxygenase-2 inhibitors in man. J Physiol Pharmacol 2008; 59 (suppl. 2):117-33.

7. Deepak L.B., Scheiman J., Abraham N.S., et al. ACCF/ACG/AHA 2008 Expert Consensus Document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Circulation 2008; 118:1894-909.

8. Hawkey C.I., Wight N.J. NSAIDs and gastrointestinal complications. LSC Life Science Communications. London, 2001:1-56.

9. Lanas A. A review of the gastrointestinal safety data – a gastroenterologist’s perspective. Rheumatology 2010; 49(suppl. 2):3-10.

10. Laponte J.-R., Ibanes L., Vidal X., et al. Upper gastrointestinal bleeding associated with the use of NSAIDs. Newer versus older agents. Drug Suf 2004; 27:411-20.

11. Malfertheiner P., Megraud F., O’Morain C., et al. Management of Helicobacter pylori infection – the Maastricht IV Florence Consensus report. Gut 2012; 61:646-64.

12. McCarthy D.M. Non-steroidal anti-inflammatory drugs: reducing the risks to the gastrointestinal drug. Clin Perspect Gastroenterol 1999; 2:219-26.

13. Richy F., Bruvere O., Ethgen O., et al. Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Pheum Dis 2004; 63:759-66.

14. Roth S.H. Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety. Clin Interv Aging 2011; 6:125-31.

15. Silverstein F.E. Improving the gastrointestinal safety of NSAIDs. The development of misoprostol – from hypothesis to clinical practice. Dig Dis Sci 1998; 43:447-58.

16. Silverstein F.E., Faich G., Goldstein J.L., et al. Gastrointestinal toxicity with cеlеcoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled study. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284:1247-55.

17. Spechler S.J. Peptic ulcer and its complications. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease. Philadelphia-London-Toronto-Montreal-SydneyTokyo 2002; 1:747-81.

18. Straube S., Tramer M.R., Moore M.A. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAIDS use. BMC Gastroenterology 2009; 9:41 doi:10.1186/1471-23OX-9-41

19. Targownik L.E., Thomson P.A. Gastroprotective strategies among NSAID users. Guidelines for appropriate use in chronic illness. Can Pharm Physician 2006; 52:110005.

20. Vane J.R., Botting R.M. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104(3A):2-8.

21. Wallace J.L. Non-steroidal anti-inflammatory drugs and gastropathy: the second hundred years. Gastroenterology 1997; 112:1000-16.

22. Wilder-Smith C.H., Robert J., Schindler D. Upper gastrointestinal tract mucosal injury by AZD3582. A COXinhibiting nitric oxide donor and naproxen: a randomized, double-blind, crossover study in healthy subjects [Abstract]. Gut 2004; 53(suppl. 6):36.